高级检索
当前位置: 首页 > 详情页

The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China [2]Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou, Peoples R China [3]Southern Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Peoples R China [4]Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian, Peoples R China [5]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurol, Wuhan, Peoples R China [6]Cent South Univ, Xiangya Hosp, Dept Neurol, Changsha, Peoples R China [7]Army Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing, Peoples R China [8]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China [9]First Hosp Jilin Univ, Dept Neurol, Changchun, Peoples R China [10]960th Hosp Joint Logist Support, Dept Neurol, PLA, Jinan, Peoples R China [11]Lanzhou Univ, Hosp 2, Dept Neurol, Lanzhou, Peoples R China [12]Shanxi Med Univ, Hosp 1, Dept Neurol, Taiyuan, Peoples R China [13]Xinjiang Uygur Autonomous Reg Peoples Hosp, Dept Neurol, Urumqi, Peoples R China [14]Sichuan Univ, West China Hosp, Dept Neurol, Chengdu, Peoples R China [15]Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Peoples R China [16]Harbin Med Univ, Affiliated Hosp 2, Dept Neurol, Harbin, Peoples R China [17]Tangshan Peoples Hosp Hebei Prov, Dept Neurol, Tangshan, Peoples R China [18]Ningxia Med Univ, Neurol Ctr, Gen Hosp, Yinchuan, Peoples R China [19]Fujian Med Univ, Affiliated Hosp 1, Dept Neurol, Fuzhou, Peoples R China [20]Nanchang Univ, Affiliated Hosp 1, Dept Neurol, Nanchang, Peoples R China [21]Guizhou Med Univ, Affiliated Hosp, Dept Neurol, Guiyang, Peoples R China [22]Inner Mongolia Peoples Hosp, Dept Neurol, Hohhot, Peoples R China [23]Hainan Med Univ, Affiliated Hosp 2, Dept Neurol, Haikou, Peoples R China [24]Guangxi Med Univ, Affiliated Hosp, Dept Neurol, Nanning, Peoples R China [25]First Peoples Hosp, Dept Neurol, Kunming, Yunnan, Peoples R China [26]Nanjing Drum Tower Hosp, Dept Neurol, Nanjing, Peoples R China [27]Naval Med Univ, Changhai Hosp, Dept Neurovasc Ctr, Shanghai, Peoples R China [28]Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin, Peoples R China [29]Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Wenzhou, Peoples R China [30]Gen Hosp Northern Theater Command, Dept Neurol, Shenyang, Peoples R China
出处:
ISSN:

关键词: critical neurological disease evaluation treatment NCCU investigation

摘要:
ObjectiveTo understand the varieties, evaluation, treatment, and prognosis of severe neurological diseases using the third NCU survey in China. DesignA cross-sectional questionnaire study. The study was completed in three main steps: filling in the questionnaire, sorting out the survey data, and analyzing the survey data. ResultsOf 206 NCUs, 165 (80%) provided relatively complete information. It was estimated that 96,201 patients with severe neurological diseases were diagnosed and treated throughout the year, with an average fatality rate of 4.1%. The most prevalent severe neurological disease was cerebrovascular disease (55.2%). The most prevalent comorbidity was hypertension (56.7%). The most prevalent complication was hypoproteinemia (24.2%). The most common nosocomial infection was hospital-acquired pneumonia (10.6%). The GCS, APACHE II, EEG, and TCD were the most commonly used (62.4-95.2%). The implementation rate of the five nursing evaluation techniques reached 55.8-90.9%. Routinely raising the head of the bed by 30 degrees, endotracheal intubation and central venous catheterization were the mostprevalent treatment strategies (97.6, 94.5, and 90.3%, respectively). Traditional tracheotomy, invasive mechanical ventilation and nasogastric tube feeding (75.8, 95.8, and 95.8%, respectively) were more common than percutaneous tracheotomy, non-invasive mechanical ventilation and nasogastric tube insertion (57.6, 57.6, and 66.7%, respectively). Body surface hypothermia brain protection technology was more commonly used than intravascular hypothermia technology (67.3 > 6.1%). The rates of minimally invasive hematoma removal and ventricular puncture were only 40.0 and 45.5%, respectively. ConclusionIn addition to traditional recognized basic life assessment and support technology, it is necessary to the use of promote specialized technology for neurological diseases, according to the characteristics of critical neurological diseases.

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 3 区 医学
小类 | 3 区 临床神经病学 3 区 神经科学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 临床神经病学 3 区 神经科学
JCR分区:
出版当年[2022]版:
Q2 CLINICAL NEUROLOGY Q2 NEUROSCIENCES
最新[2023]版:
Q2 CLINICAL NEUROLOGY Q3 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:87344 今日访问量:0 总访问量:719 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号